Reduced Services (effective May 18, 2020)

The Transgenic and Targeting Shared Resource is resuming operations at a reduced level, initially performing only microinjections (CRISPR/Cas gene editing).

Before we resume work on a project, we will coordinate with primary investigators to ensure they will have the ability to accept mice in 7-8 weeks.

While eager to get back to work, we are keenly aware of the challenges new public health recommendations pose to the nature of our services.  As we learn from our experience, we will consider adding additional services or increasing throughput.

Transgenic and Targeting


The Case Transgenic and Targeting Shared Resource (SR) serves by generating transgenic and gene-targeted mice, in addition to pathogen control, cryopreservation and other services.

Services provided:

  • Transgenic
  • Targeting
  • Chimera
  • Rederivation
  • Cryopreservation
  • Transfection
  • ES cell line
  • Surgery
  • In vitro Fertilization (IVF)
  • Training


Remember to acknowledge the valuable services provided by Cancer Center Shared Resources in your research papers and publications: 
"This research was supported by the Transgenic & Targeting Shared Resource of the Case Comprehensive Cancer Center (P30 CA43703)."

Public Office Location Wolstein Research Bldg. 2-514
Director Ronald A. Conlon, PhD
Manager Rachel Mann, PhD